We are live on ! Find out more
DG

Delek Group Portfolio holdings

AUM $2.59B
1-Year Est. Return 1.24%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
-1.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.59B
AUM Growth
+$180M
Cap. Flow
+$192M
Cap. Flow %
7.41%
Top 10 Hldgs %
27.3%
Holding
255
New
49
Increased
70
Reduced
72
Closed
35

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$28.1M
2
IHF icon
iShares US Healthcare Providers ETF
IHF
+$28.1M
3
NEM icon
Newmont
NEM
+$23.7M
4
FCX icon
Freeport-McMoran
FCX
+$22.1M
5
TCOM icon
Trip.com Group
TCOM
+$22.1M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$50.7M
2
IFF icon
International Flavors & Fragrances
IFF
+$43.1M
3
META icon
Meta Platforms (Facebook)
META
+$25.2M
4
SCCO icon
Southern Copper
SCCO
+$19.3M
5
MLNX
Mellanox Technologies, Ltd.
MLNX
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 14.15%
2 Healthcare 11.72%
3 Industrials 9.3%
4 Materials 8.43%
5 Energy 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORGS
201
DELISTED
Orgenesis Inc. Common Stock
ORGS
$278K 0.01%
+6,400
New +$289K
HEDJ icon
202
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
$251K 0.01%
7,772
-8,128
-51% -$267K
KR icon
203
Kroger
KR
$35.4B
$233K 0.01%
11,000
-399,667
-97% -$9.72M
DSPG
204
DELISTED
DSP Group Inc
DSPG
$227K 0.01%
16,203
-3,211
-17% -$46.3K
NBL
205
CALL
DELISTED
Noble Energy, Inc.
NBL
$224K 0.01%
+10,000
New +$237K
NBL
206
PUT
DELISTED
Noble Energy, Inc.
NBL
$224K 0.01%
10,000
– –
CRNT icon
207
Ceragon Networks
CRNT
$207M
$178K 0.01%
62,180
+9,977
+19% +$32.6K
GLMD icon
208
Galmed Pharmaceuticals
GLMD
$3.99M
$176K 0.01%
136
+18
+15% +$23.2K
OPK icon
209
Opko Health
OPK
$914M
$174K 0.01%
73,000
– –
AUDC icon
210
CALL
AudioCodes
AUDC
$250M
$156K 0.01%
+10,100
New +$154K
GMDA
211
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$145K 0.01%
29,203
– –
FOMX
212
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$145K 0.01%
62,437
+11,741
+23% +$35.1K
BCLI
213
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$139K 0.01%
2,394
-429
-15% -$25K
INDP icon
214
Indaptus Therapeutics
INDP
$336M
$137K 0.01%
14
+5
+56% +$63.1K
BLRX
215
BioLineRX
BLRX
$12.7M
$134K 0.01%
625
+266
+74% +$59.7K
ADMA icon
216
CALL
ADMA Biologics
ADMA
$1.99B
$132K 0.01%
+34,000
New +$150K
ADMA icon
217
ADMA Biologics
ADMA
$1.99B
$129K 0.01%
34,034
-30,000
-47% -$132K
ARTX
218
DELISTED
Arotech Corporation
ARTX
$115K ﹤0.01%
58,985
+6,587
+13% +$16.5K
CMMB
219
Chemomab Therapeutics
CMMB
$10.8M
$114K ﹤0.01%
408
– –
ALLT icon
220
CALL
Allot
ALLT
$395M
– –
-35,100
Closed -$224K
BAC icon
221
Bank of America
BAC
$430B
– –
-328,696
Closed -$9.06M
CFG icon
222
Citizens Financial Group
CFG
$30.4B
– –
-325,000
Closed -$10.5M
DFS
223
DELISTED
Discover Financial Services
DFS
– –
-96,000
Closed -$6.8M
EWY icon
224
iShares MSCI South Korea ETF
EWY
$23.1B
– –
-8,460
Closed -$513K
FL
225
DELISTED
Foot Locker
FL
– –
-46,511
Closed -$2.81M
7 8
9
10 11

Similar funds

KPAG
KLS Professional Advisors Group New York $2.15B AUM 6.46% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
LC
Lourd Capital Beverly Hills, California $1.08B AUM 8.79% 1-Year Est. Return
LIC
Lodestar Investment Counsel Chicago, Illinois $974M AUM 13.79% 1-Year Est. Return
CB
Chemical Bank Detroit, Michigan $881M AUM 4.54% 1-Year Est. Return

Delek Group's Q2 2019 Portfolio in Review

As of Q2 2019, Delek Group held 255 positions worth $2.59B, up 7.5% from $2.41B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Delek Group deployed $192M of net new capital in Q2 2019, opening 49 new positions and adding to 70 existing holdings. Its largest new stake was Philip Morris: 340,000 shares worth $26.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $50.7M trimmed.

  • Delek Group's largest Q2 2019 buy was Philip Morris: 340,000 shares worth $26.4M.
  • Delek Group added most to iShares US Healthcare Providers ETF in Q2 2019, an estimated $28.1M increase.
  • Delek Group's biggest Q2 2019 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $50.7M.
  • Delek Group fully exited Southern Copper in Q2 2019, selling an estimated $19.3M.
  • Delek Group's ten largest holdings make up 27% of its $2.59B portfolio in Q2 2019.
  • Delek Group opened 49 new positions and closed 35 in Q2 2019.
  • Delek Group's portfolio value rose 7.5% quarter-over-quarter to $2.59B.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.